AstraZeneca published an article in MIT Technology Review exploring how AI is embedded across biologics discovery to identify potential new biologics for development in weeks instead of months.
Public source
Publisher name
Public post
How is AI helping scientists discover and design biologic medicines? Our latest article in MIT Technology Review explores how AstraZeneca is embedding AI across biologic…
Company
AstraZeneca
- Industry
- Pharmaceutical Manufacturing
- Location
- Cambridge, GB
- Company size
- 10,001+ employees
About AstraZeneca
We're transforming the future of healthcare by unlocking the power of what science can do for people, society and the planet. For more information, visit www.astrazeneca.com. Community Guidelines: bit.ly/2MgAcio
See moreLatest activity
Latest activity from AstraZeneca
141 signals
Presence & Recognition
AstraZeneca leaders share their vision for how continued scientific progress could transform what is possible by 2040 as they head into WCLC 2026
Presence & Recognition
AstraZeneca is reflecting on the future of lung cancer care ahead of WCLC 2026.
Research & Knowledge
AstraZeneca and partner Amgen announced positive high-level Phase III results from the DeLLphi-305 trial in extensive-stage small cell lung cancer.
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Pharmatica
Pharmatica published Pharmatica Insights exploring the race to build an AI-driven digital organism and virtual biology for pharmaceutical R&D.
Research & Knowledge
The Association of the British Pharmaceutical Industry (ABPI)
The Association of the British Pharmaceutical Industry (ABPI) published the new UK Pharmaceutical Investment Competitiveness Report 2026, which reveals that since September 2025, £2 billion of new investment has been committed to the UK spanning AI-enabled drug discovery through to large-scale manufacturing.
Research & Knowledge
PSI CRO
PSI CRO published a white paper examining the operational reality of agentic AI in clinical development, including how AI is applied across feasibility, trial management, decision support, and execution oversight in complex global studies.
Research & Knowledge
Eli Lilly and Company
Eli Lilly and Company published a perspective article on Science Direct discussing the evolution of digital twins in biopharma manufacturing.
Research & Knowledge
Takeda